Search Results - "Ferreira, Valerie"
-
1
Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy
Published in Human gene therapy (01-03-2014)“…Cellular immune responses to adeno-associated viral (AAV) vectors used for gene therapy have been linked to attenuated transgene expression and loss of…”
Get more information
Journal Article -
2
Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer
Published in Molecular therapy. Methods & clinical development (13-12-2019)“…As gene transfer with adeno-associated virus (AAV) vectors is starting to enter clinical practice, this review examines the impact of vector capsid choice in…”
Get full text
Journal Article -
3
Cell-Based Tracers as Trojan Horses for Image-Guided Surgery
Published in International journal of molecular sciences (13-01-2021)“…Surgeons rely almost completely on their own vision and palpation to recognize affected tissues during surgery. Consequently, they are often unable to…”
Get full text
Journal Article -
4
Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates
Published in Blood advances (10-09-2019)“…Adeno-associated virus (AAV)–based liver gene therapy has been shown to be clinically successful. However, the presence of circulating neutralizing antibodies…”
Get full text
Journal Article -
5
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1
Published in Molecular therapy (02-08-2017)“…In the gene therapy field, re-administration of adeno-associated virus (AAV) is an important topic because a decrease in therapeutic protein expression might…”
Get full text
Journal Article -
6
Enhanced Factor IX Activity following Administration of AAV5-R338L “Padua” Factor IX versus AAV5 WT Human Factor IX in NHPs
Published in Molecular therapy. Methods & clinical development (13-12-2019)“…Gene therapy for severe hemophilia B is advancing and offers sustained disease amelioration with a single treatment. We have reported the efficacy and safety…”
Get full text
Journal Article -
7
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis
Published in World journal of gastroenterology : WJG (28-08-2012)“…AIM:To explore the anti-inflammatory potential of adeno-associated virus-mediated delivery of Tregitope 167 in an experimental colitis model.METHODS:The…”
Get full text
Journal Article -
8
Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease
Published in Human vaccines & immunotherapeutics (01-10-2012)“…Babies born with Pompe disease require life-long treatment with enzyme-replacement therapy (ERT). Despite the human origin of the therapy, recombinant human…”
Get full text
Journal Article -
9
Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo
Published in BMC gastroenterology (03-12-2012)“…Induced regulatory T (iTreg) lymphocytes show promise for application in the treatment of allergic, autoimmune and inflammatory disorders. iTreg cells…”
Get full text
Journal Article -
10
Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses
Published in Arteriosclerosis, thrombosis, and vascular biology (01-10-2006)“…OBJECTIVE—Atherosclerosis is an inflammatory disease in which macrophage activation and lipid loading play a crucial role. In this study, we investigated…”
Get full text
Journal Article -
11
Current use of benzodiazepines in anxiety disorders
Published in Current opinion in psychiatry (01-01-2009)“…PURPOSE OF REVIEWThe aim of this study is to provide a review of articles published between July 2007 and August 2008 on the current use and rationale of…”
Get full text
Journal Article -
12
Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients
Published in Molecular therapy (01-06-2016)“…Recombinant adeno-associated viral vectors (rAAV) currently constitute a real therapeutic strategy for the sustained correction of diverse genetic conditions…”
Get full text
Journal Article -
13
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
Published in European journal of cancer (1990) (01-09-2008)“…Abstract Angiogenesis is crucial for the progression of colorectal carcinomas in which the bioavailability of Vascular Endothelial Growth Factor (VEGF) plays a…”
Get full text
Journal Article -
14
Gene and cell therapy based treatment strategies for inflammatory bowel diseases
Published in World journal of gastrointestinal pathophysiology (15-12-2011)“…Inflammatory bowel diseases(IBD)are a group of chronic inflammatory disorders most commonly affecting young adults.Currently available therapies can result in…”
Get full text
Journal Article -
15
701. Successful In Vivo Re-Administration of AAV with the Use of Two-Step AAV Injection
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
16
Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside
Published in Frontiers in immunology (2014)“…Alipogene tiparvovec (Glybera(®)) is an adeno-associated virus serotype 1 (AAV1)-based gene therapy that has been developed for the treatment of patients with…”
Get full text
Journal Article -
17
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs
Published in Molecular therapy. Methods & clinical development (13-09-2019)“…Currently, individuals with pre-existing neutralizing antibodies (NABs) against adeno-associated virus (AAV) above titer of 5 are excluded from systemic…”
Get full text
Journal Article -
18
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
Published in Gene therapy (01-04-2013)“…We describe the 2-year follow-up of an open-label trial (CT-AMT-011–01) of AAV1-LPL S447X gene therapy for lipoprotein lipase (LPL) deficiency (LPLD), an…”
Get full text
Journal Article -
19
-
20
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Published in Nature (London) (04-04-1996)“…The endothelial cell-specific vascular endothelial growth factor (VEGF) and its cellular receptors Flt-1 and Flk-1 have been implicated in the formation of the…”
Get full text
Journal Article